Sun Pharma share price has seen a 10% decline in year-to-date (YTD) performance and an 11% drop over the past six months.
Sun Pharmaceutical Industries Ltd. closed 9.70% below its 52-week high of 1,960.20 rupees, which the company reached on ...
3d
ET Now on MSNTariff Impact: Sun Pharma, Lupin, Gland Pharma, Cipla and other pharma stocks rally up to 14% - Here's whyDonald Trump has announced reciprocal tariffs on about 60 countries, including India. He announced 27 per cent reciprocal ...
Sun Pharmaceutical Industries Ltd. closed 12.55% short of its 52-week high of 1,960.20 rupees, which the company reached on ...
Emrosiâ„¢ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ...
Vogue Williams and Spencer Matthews have sold their incredible £5.25million London home in a search for a bigger property for ...
NEW YORK (AP) — A NASA spacecraft will make another close brush with the sun, the second of three planned encounters through the sizzling solar atmosphere. Webb Space Telescope captures a star ...
Venus could make a brief appearance this weekend as it passes between the Earth and the sun. Just be warned: It won't be easy to spot in the sun's glow, according to astronomers. The orbit Venus ...
Sun Pharma, the largest pharmaceutical company in India, issued one advisory on March 18 cautioning their CFAs and distributors about the rising menace of counterfeit and substandard medicines in the ...
Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results